(Q83764954)
Statements
Canagliflozin, a novel inhibitor of sodium glucose co-transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects (English)
S Sha
D Devineni
A Ghosh
D Polidori
S Chien
D Wexler
K Shalayda
K Demarest